Liping Liu

4.1k total citations
109 papers, 3.1k citations indexed

About

Liping Liu is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Liping Liu has authored 109 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Molecular Biology, 33 papers in Cancer Research and 23 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Liping Liu's work include MicroRNA in disease regulation (12 papers), Cancer-related molecular mechanisms research (10 papers) and Acute Ischemic Stroke Management (8 papers). Liping Liu is often cited by papers focused on MicroRNA in disease regulation (12 papers), Cancer-related molecular mechanisms research (10 papers) and Acute Ischemic Stroke Management (8 papers). Liping Liu collaborates with scholars based in China, United States and Australia. Liping Liu's co-authors include M. Celeste Simon, Jun Li, Libing Song, Hui Tao, Jingjing Yang, Anja Runge, Brian Keith, Nicolas Skuli, Mengfeng Li and Jueheng Wu and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Liping Liu

108 papers receiving 3.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Liping Liu China 30 1.8k 999 427 357 301 109 3.1k
Yingjian Liang China 29 1.6k 0.9× 999 1.0× 507 1.2× 356 1.0× 287 1.0× 94 3.0k
Huarong Chen China 37 2.2k 1.2× 1.2k 1.2× 685 1.6× 312 0.9× 402 1.3× 103 3.4k
Shuijun Zhang China 27 1.7k 1.0× 878 0.9× 406 1.0× 384 1.1× 256 0.9× 176 2.9k
Tao Xu China 30 1.6k 0.9× 723 0.7× 211 0.5× 447 1.3× 157 0.5× 127 2.8k
Xiaojie Lu China 34 2.1k 1.2× 1.1k 1.1× 758 1.8× 518 1.5× 307 1.0× 113 3.8k
Yanhong Zhang China 31 2.0k 1.1× 816 0.8× 807 1.9× 325 0.9× 344 1.1× 139 3.4k
Qing Li China 37 2.7k 1.5× 1.1k 1.1× 711 1.7× 777 2.2× 336 1.1× 169 4.7k
Wei Yao China 31 1.2k 0.7× 646 0.6× 648 1.5× 304 0.9× 266 0.9× 121 2.6k
Zongfang Li China 32 1.2k 0.7× 551 0.6× 461 1.1× 314 0.9× 239 0.8× 116 2.7k
Weilong Zhong China 27 1.8k 1.0× 593 0.6× 548 1.3× 224 0.6× 201 0.7× 91 2.6k

Countries citing papers authored by Liping Liu

Since Specialization
Citations

This map shows the geographic impact of Liping Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liping Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liping Liu more than expected).

Fields of papers citing papers by Liping Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liping Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liping Liu. The network helps show where Liping Liu may publish in the future.

Co-authorship network of co-authors of Liping Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Liping Liu. A scholar is included among the top collaborators of Liping Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liping Liu. Liping Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Liping, et al.. (2025). Mapping existing research on flushing peripheral vascular catheters: a scoping review protocol. BMJ Open. 15(1). e088912–e088912.
3.
Xie, Ning, Xiaobo Hu, Yu Tang, et al.. (2022). Impact of surgical management of primary tumors in stage IV breast cancer patients: a retrospective observational study based on SEER database. BMJ Open. 12(2). e054135–e054135. 2 indexed citations
4.
Ouyang, Quchang, Liping Liu, Jingyu Liu, et al.. (2019). Chemotherapy Modulates Endocrine Therapy-Related Resistance Mutations in Metastatic Breast Cancer. Translational Oncology. 12(5). 764–774. 12 indexed citations
5.
Chen, Yuhua, Lingling Meng, Haitao Shang, et al.. (2018). β2 spectrin-mediated differentiation repressed the properties of liver cancer stem cells through β-catenin. Cell Death and Disease. 9(4). 424–424. 15 indexed citations
6.
Jiang, Zongzhe, Jingjing Tian, Wenjian Zhang, et al.. (2017). Forkhead Protein FoxO1 Acts as a Repressor to Inhibit Cell Differentiation in Human Fetal Pancreatic Progenitor Cells. Journal of Diabetes Research. 2017. 1–6. 6 indexed citations
7.
Liu, Liping, et al.. (2017). MicroRNA-1 upregulation promotes myocardiocyte proliferation and suppresses apoptosis during heart development. Molecular Medicine Reports. 15(5). 2837–2842. 19 indexed citations
8.
Liu, Liping, et al.. (2017). [Depletion of GP73 inhibits invasion and metastasis of hepatocellular carcinoma cells].. PubMed. 39(7). 497–501. 3 indexed citations
9.
Zhang, Liqun, Xiaoling Liao, Yuesong Pan, et al.. (2015). Unfavorable Outcome of Thrombolysis in Chinese Patients with Cardioembolic Stroke: a Prospective Cohort Study. CNS Neuroscience & Therapeutics. 21(8). 657–661. 30 indexed citations
10.
Miao, Zhongrong, Xingquan Zhao, Peiyi Gao, et al.. (2014). Protocol for a prospective, multicentre registry study of stenting for symptomatic intracranial artery stenosis in China. BMJ Open. 4(8). e005175–e005175. 17 indexed citations
11.
Yang, Jingjing, Hui Tao, Wei Hu, et al.. (2014). MicroRNA-200a controls Nrf2 activation by target Keap1 in hepatic stellate cell proliferation and fibrosis. Cellular Signalling. 26(11). 2381–2389. 81 indexed citations
12.
Liu, Liping, Kun Chen, Jueheng Wu, et al.. (2013). Downregulation of miR-452 Promotes Stem-Like Traits and Tumorigenicity of Gliomas. Clinical Cancer Research. 19(13). 3429–3438. 38 indexed citations
13.
Fang, Yan, Liping Liu, Peter J. Dempsey, et al.. (2013). A Lactobacillus rhamnosus GG-derived Soluble Protein, p40, Stimulates Ligand Release from Intestinal Epithelial Cells to Transactivate Epidermal Growth Factor Receptor. Journal of Biological Chemistry. 288(42). 30742–30751. 132 indexed citations
14.
Yu, Chunping, Zhiling Zhang, Wenting Liao, et al.. (2012). The tumor-suppressor gene Nkx2.8 suppresses bladder cancer proliferation through upregulation of FOXO3a and inhibition of the MEK/ERK signaling pathway. Carcinogenesis. 33(3). 678–686. 39 indexed citations
15.
Zheng, Hongwei, Yilong Wang, Yilong Wang, et al.. (2012). Circulating MicroRNAs as Potential Risk Biomarkers for Hematoma Enlargement after Intracerebral Hemorrhage. CNS Neuroscience & Therapeutics. 18(12). 1003–1011. 50 indexed citations
16.
Liu, Liping, Jueheng Wu, Zhe Ying, et al.. (2010). Astrocyte Elevated Gene-1 Upregulates Matrix Metalloproteinase-9 and Induces Human Glioma Invasion. Cancer Research. 70(9). 3750–3759. 136 indexed citations
17.
Song, Libing, Quan Huang, Kun Chen, et al.. (2010). miR-218 inhibits the invasive ability of glioma cells by direct downregulation of IKK-β. Biochemical and Biophysical Research Communications. 402(1). 135–140. 118 indexed citations
18.
Liu, Liping, Miriam Zacchia, Xuefei Tian, et al.. (2010). Acid regulation of NaDC-1 requires a functional endothelin B receptor. Kidney International. 78(9). 895–904. 20 indexed citations
19.
Skuli, Nicolas, Liping Liu, Anja Runge, et al.. (2009). Endothelial deletion of hypoxia-inducible factor–2α (HIF-2α) alters vascular function and tumor angiogenesis. Blood. 114(2). 469–477. 209 indexed citations
20.
Liu, Liping. (2007). Exploration of Blog-based Learning Support Services System of Modern Distance Higher Education. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026